Hong Kong-listed biotechnology stocks rallied amid volatility, with CanSino Biologics (06185.HK) surging over 10%, WuXi AppTec (02126.HK) rising over 6%, and Everest Medicines (01952.HK) and CStone Pharmaceuticals-B (02616.HK) also following suit.
2026-09-23
Hong Kong-listed biotechnology stocks rallied amid volatility, with CanSino Biologics (06185.HK) surging over 10%, WuXi AppTec (02126.HK) rising over 6%, and Everest Medicines (01952.HK) and CStone Pharmaceuticals-B (02616.HK) also following suit.